Literature DB >> 19307178

Engineered human antibody constant domains with increased stability.

Rui Gong1, Bang K Vu, Yang Feng, DaRue A Prieto, Marzena A Dyba, Joseph D Walsh, Ponraj Prabakaran, Timothy D Veenstra, Sergey G Tarasov, Rieko Ishima, Dimiter S Dimitrov.   

Abstract

The immunoglobulin (Ig) constant CH2 domain is critical for antibody effector functions. Isolated CH2 domains are promising as scaffolds for construction of libraries containing diverse binders that could also confer some effector functions. However, previous work has shown that an isolated murine CH2 domain is relatively unstable to thermally induced unfolding. To explore unfolding mechanisms of isolated human CH2 and increase its stability gamma1 CH2 was cloned and a panel of cysteine mutants was constructed. Human gamma1 CH2 unfolded at a higher temperature (T(m) = 54.1 degrees C, as measured by circular dichroism) than that previously reported for a mouse CH2 (41 degrees C). One mutant (m01) was remarkably stable (T(m) = 73.8 degrees C). Similar results were obtained by differential scanning calorimetry. This mutant was also significantly more stable than the wild-type CH2 against urea induced unfolding (50% unfolding at urea concentration of 6.8 m versus 4.2 m). The m01 was highly soluble and monomeric. The existence of the second disulfide bond in m01 and its correct position were demonstrated by mass spectrometry and nuclear magnetic resonance spectroscopy, respectively. The loops were on average more flexible than the framework in both CH2 and m01, and the overall secondary structure was not affected by the additional disulfide bond. These data suggest that a human CH2 domain is relatively stable to unfolding at physiological temperature, and that both CH2 and the highly stable mutant m01 are promising new scaffolds for the development of therapeutics against human diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19307178      PMCID: PMC2682868          DOI: 10.1074/jbc.M900769200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Engineering novel binding proteins from nonimmunoglobulin domains.

Authors:  H Kaspar Binz; Patrick Amstutz; Andreas Plückthun
Journal:  Nat Biotechnol       Date:  2005-10       Impact factor: 54.908

2.  AutoLink: automated sequential resonance assignment of biopolymers from NMR data by relative-hypothesis-prioritization-based simulated logic.

Authors:  James E Masse; Rochus Keller
Journal:  J Magn Reson       Date:  2005-05       Impact factor: 2.229

Review 3.  Engineered antibody fragments and the rise of single domains.

Authors:  Philipp Holliger; Peter J Hudson
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

Review 4.  Artificial, non-antibody binding proteins for pharmaceutical and industrial applications.

Authors:  Thomas Hey; Erik Fiedler; Rainer Rudolph; Markus Fiedler
Journal:  Trends Biotechnol       Date:  2005-10       Impact factor: 19.536

5.  Multi-template approach to modeling engineered disulfide bonds.

Authors:  Jean-Luc Pellequer; Shu-wen W Chen
Journal:  Proteins       Date:  2006-10-01

6.  Folding mechanism of the CH2 antibody domain.

Authors:  Matthias J Feige; Stefan Walter; Johannes Buchner
Journal:  J Mol Biol       Date:  2004-11-12       Impact factor: 5.469

7.  15N-{1H} NOE experiment at high magnetic field strengths.

Authors:  Qingguo Gong; Rieko Ishima
Journal:  J Biomol NMR       Date:  2007-01-16       Impact factor: 2.835

8.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

9.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

10.  How to measure and predict the molar absorption coefficient of a protein.

Authors:  C N Pace; F Vajdos; L Fee; G Grimsley; T Gray
Journal:  Protein Sci       Date:  1995-11       Impact factor: 6.725

View more
  40 in total

Review 1.  Therapeutic proteins.

Authors:  Dimiter S Dimitrov
Journal:  Methods Mol Biol       Date:  2012

2.  Evaluation of a noncanonical Cys40-Cys55 disulfide linkage for stabilization of single-domain antibodies.

Authors:  Dae Young Kim; Hiba Kandalaft; Greg Hussack; Shalini Raphael; Wen Ding; John F Kelly; Kevin A Henry; Jamshid Tanha
Journal:  Protein Sci       Date:  2019-03-14       Impact factor: 6.725

3.  Engineered soluble monomeric IgG1 CH3 domain: generation, mechanisms of function, and implications for design of biological therapeutics.

Authors:  Tianlei Ying; Weizao Chen; Yang Feng; Yanping Wang; Rui Gong; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2013-07-18       Impact factor: 5.157

4.  Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domains.

Authors:  Weizao Chen; Yang Feng; Ponraj Prabakaran; Tianlei Ying; Yanping Wang; Jianping Sun; Camila D S Macedo; Zhongyu Zhu; Yuxian He; Victoria R Polonis; Dimiter S Dimitrov
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

5.  Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor.

Authors:  Rui Gong; Yanping Wang; Yang Feng; Qi Zhao; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

6.  Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.

Authors:  Ranajoy Majumdar; Reza Esfandiary; Steven M Bishop; Hardeep S Samra; C Russell Middaugh; David B Volkin; David D Weis
Journal:  MAbs       Date:  2015       Impact factor: 5.857

7.  Engineering an IgG Scaffold Lacking Effector Function with Optimized Developability.

Authors:  Frederick W Jacobsen; Riki Stevenson; Cynthia Li; Hossein Salimi-Moosavi; Ling Liu; Jie Wen; Quanzhou Luo; Kristine Daris; Lynette Buck; Sterling Miller; Shu-Yin Ho; Wei Wang; Qing Chen; Kenneth Walker; Jette Wypych; Linda Narhi; Kannan Gunasekaran
Journal:  J Biol Chem       Date:  2016-12-19       Impact factor: 5.157

8.  High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation.

Authors:  Mohammad A Alsenaidy; Jae Hyun Kim; Ranajoy Majumdar; David D Weis; Sangeeta B Joshi; Thomas J Tolbert; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2013-09-24       Impact factor: 3.534

9.  Yeast display of engineered antibody domains.

Authors:  Qi Zhao; Zhongyu Zhu; Dimiter S Dimitrov
Journal:  Methods Mol Biol       Date:  2012

10.  Expression, purification, and characterization of engineered antibody CH2 and VH domains.

Authors:  Rui Gong; Weizao Chen; Dimiter S Dimitrov
Journal:  Methods Mol Biol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.